News & Insights
Sort By
Insights 2 Results
Insights
|March 23, 2026
Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure’s article, "The Legal Playbook for Building a Biotech Company, From Formation to Financing," which discusses how a biotech company’s legal needs shift quickly as it grows and explores how founders can build the right legal foundation, avoid common missteps, and bring in the right counsel at the right time.
Insights
|March 11, 2026
Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure's article, "Technology Transfer in Biotech and Pharma and the Process of Scaling New Medicines," which explains how technology transfer works in biotech and pharma, the different types of transfers, and why poor execution can delay commercialization.
Events 7 Results
Events
|March 17, 2026
Post-IPO: Engaging Shareholders with Confidence and Credibility
This webinar equips GCs and CFOs of public companies with strategies to navigate shareholder communications, from annual meetings to investor engagement, with insights from Gunderson Dettmer’s Alexa Belonick and Brett Pletcher
Events
|July 29, 2024
Webinar: Going from Back-office Fixer to Strategic Partner
Gunderson Dettmer Advisor and former Gilead General Counsel Brett Pletcher hosts the second-part of his three-part webinar series on “Building the General Counsel Role in Venture-Backed Companies”
Events
|July 17, 2024
Gunderson Dettmer Webinar Series: Building the General Counsel Role in Venture-Backed Companies
Gunderson Dettmer Advisor and former Gilead General Counsel Brett Pletcher to host a free, three-part series of webinars to help GCs and heads of legal assess the challenges that may be constraining their current roles, identify and develop the relationships necessary to grow their roles and create strategies for building their roles and functions over time.